Monaco Asset Management SAM
- SEC CIK
- 0001803593
- Latest filing
- Aug 7, 2026
CUE holding history
Cue Biopharma, Inc. in every 13F filed by Monaco Asset Management SAM, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CUE overviewAll 13F holders of CUEFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −253,185−100.0% | Sold out | Holders |
| Q2 2024 | 253,185 | $313.9K | 0.2% | −81,557−24.4% | Reduced | Holders |
| Q1 2024 | 334,742 | $632.7K | 0.3% | −7,500−2.2% | Reduced | Holders |
| Q4 2023 | 342,242 | $903.5K | 0.3% | −17,497−4.9% | Reduced | Holders |
| Q3 2023 | 359,739 | $827.4K | 0.4% | −10,668−2.9% | Reduced | Holders |
| Q2 2023 | 370,407 | $1.35M | 0.7% | −95,938−20.6% | Reduced | Holders |
| Q1 2023 | 466,345 | $1.66M | 0.7% | −30,832−6.2% | Reduced | Holders |
| Q4 2022 | 497,177 | $1.42M | 0.5% | +38,326+8.4% | Added | Holders |
| Q3 2022 | 458,851 | $1.02M | 0.5% | +15,000+3.4% | Added | Holders |
| Q2 2022 | 443,851 | $1.10M | 0.5% | +398,851+886.3% | Added | Holders |
| Q1 2022 | 45,000 | $220.0K | 0.1% | +45,000 | New | Holders |